These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3001285)

  • 1. Cardiac and coronary effects of prazosin and phenoxybenzamine during coronary hypotension.
    Jones CE; Liang IY; Maulsby MR
    J Pharmacol Exp Ther; 1986 Jan; 236(1):204-11. PubMed ID: 3001285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonselective and selective alpha 1-adrenergic blockade on coronary blood flow during exercise.
    Bache RJ; Dai XZ; Herzog CA; Schwartz JS
    Circ Res; 1987 Nov; 61(5 Pt 2):II36-41. PubMed ID: 2822283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that a coronary alpha-adrenergic tone limits myocardial blood flow and oxygenation in acute hemorrhagic hypotension.
    Jones CE; Farrell TA; Ator R
    Circ Shock; 1983; 11(4):329-40. PubMed ID: 6661814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-adrenergic blockade increases coronary blood flow during coronary hypoperfusion.
    Liang IY; Jones CE
    Am J Physiol; 1985 Dec; 249(6 Pt 2):H1070-7. PubMed ID: 2866717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of coronary alpha 1-adrenoceptors of the dog heart in dopamine-induced cardiostimulation evidenced by treatment with prazosin.
    Kékesi V; Rabloczky G; Mader MR; Juhász-Nagy A
    Acta Physiol Hung; 1989; 73(1):61-9. PubMed ID: 2540619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary blood flow and myocardial oxygen consumption after alpha adrenergic blockade during submaximal exercise.
    Gwirtz PA; Stone HL
    J Pharmacol Exp Ther; 1981 Apr; 217(1):92-8. PubMed ID: 6110777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
    Bache RJ; Homans DC; Schwartz JS; Dai XZ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):232-7. PubMed ID: 2896237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
    Strader JR; Gwirtz PA; Jones CE
    J Pharmacol Exp Ther; 1988 Aug; 246(2):772-8. PubMed ID: 2900330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries.
    Kopia GA; Kopaciewicz LJ; Ruffolo RR
    J Pharmacol Exp Ther; 1986 Dec; 239(3):641-7. PubMed ID: 2879028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenergic tone in the coronary circulation of the conscious dog.
    Vatner SF
    Fed Proc; 1984 Nov; 43(14):2867-72. PubMed ID: 6092145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary alpha-adrenergic stimulation does not alter the heterogeneity of myocardial blood flow and oxygen utilization.
    Conway RS; Acad BA; Weiss HR
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):285-314. PubMed ID: 2177832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial oxygen consumption and blood flow during nicotine infusion: effect of combined alpha- and beta-adrenergic blockade.
    Crystal GJ; Downey HF; Bashour FA
    J Cardiovasc Pharmacol; 1981; 3(2):317-27. PubMed ID: 6166803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary blood flow during exercise following nonselective and selective alpha 1-adrenergic blockade with indoramin.
    Dai XZ; Herzog CA; Schwartz JS; Bache RJ
    J Cardiovasc Pharmacol; 1986; 8(3):574-81. PubMed ID: 2425176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenergic coronary vasoconstriction during myocardial underperfusion.
    Feigl EO; Buffington CW; Nathan HJ
    Circulation; 1987 Jan; 75(1 Pt 2):I1-5. PubMed ID: 3024862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-adrenergic blockade on coronary blood flow of dogs in hemorrhagic shock.
    Birinyi F; Hackel DB; Mikat E
    Circ Shock; 1977; 4(4):297-303. PubMed ID: 598003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-adrenergic blockade on coronary autoregulation in dogs.
    Jones CE; Liang IY; Gwirtz PA
    Am J Physiol; 1987 Aug; 253(2 Pt 2):H365-72. PubMed ID: 2887121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postsynaptic alpha 1- and alpha 2-adrenergic mechanisms in coronary vasoconstriction.
    Chen DG; Dai XZ; Zimmerman BG; Bache RJ
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):61-7. PubMed ID: 2450258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha and beta adrenergic blockade on oxygen transport in rat skeletal muscle and brain.
    Weiss HR; Lipp JA; Neubauer JA; Feldman RS
    J Pharmacol Exp Ther; 1976 Aug; 198(2):403-11. PubMed ID: 948032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-adrenergic constriction limits coronary flow and cardiac function in running dogs.
    Gwirtz PA; Overn SP; Mass HJ; Jones CE
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1117-26. PubMed ID: 3013025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.